Reference health
Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery
1 of 114 checkable references need attention · checked 2026-07-23
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
marked retracted — notice via Crossref, record curated by Retraction Watch10.1016/j.ygyno.2008.04.033
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
The 113 checked references that resolve
resolves10.1002/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.0.CO;2-1
Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes
resolves10.1081/CNV-120014883
Pegylated Liposomal Doxorubicin (Doxil<sup>®</sup>) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience
resolves10.1016/S0959-8049(01)00216-7
Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck
resolves10.1054/bjoc.2001.2149
Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma
resolves10.1097/00001813-200010000-00002
Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
resolves10.1016/j.ygyno.2003.12.037
A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer
resolves10.1081/CNV-120016412
Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma<sup>*</sup>
resolves10.1002/cncr.11593
Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T‐cell lymphoma
resolves10.1086/377542
Single‐Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study
resolves10.1097/00000542-200407000-00021
A Novel Liposomal Bupivacaine Formulation to Produce Ultralong-Acting Analgesia
resolves10.1016/0092-8674(83)90040-5
Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor
resolves10.1016/j.ceb.2004.06.003
Exosomes: endosomal-derived vesicles shipping extracellular messages
resolves10.1074/jbc.273.32.20121
Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes
resolves10.1038/nm0598-594
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes
resolves10.1016/j.mcn.2010.11.004
Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity
resolves10.1074/jbc.M110.190009
Inhibition of Myelin Membrane Sheath Formation by Oligodendrocyte-derived Exosome-like Vesicles
resolves10.1073/pnas.0710608105
The fusing ability of sperm is bestowed by CD9-containing vesicles released from eggs in mice
resolves10.1016/j.scr.2009.12.003
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
resolves10.1681/ASN.2008070798
Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury
resolves10.1111/j.1600-0854.2009.01006.x
HIV Nef is Secreted in Exosomes and Triggers Apoptosis in Bystander CD4<sup>+</sup> T Cells
resolves10.4049/jimmunol.1001145
Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro
resolves10.1074/jbc.M702277200
Exosomes Released from Infected Macrophages Contain Mycobacterium avium Glycopeptidolipids and Are Proinflammatory
resolves10.1080/14653240600855905
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
resolves10.1158/0008-5472.CAN-06-1819
Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T Lymphocytes
resolves10.1038/nbt.1807
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
resolves10.4049/jimmunol.172.4.2126
Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells
resolves10.1038/ncb1596
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
resolves10.1158/0008-5472.CAN-10-4455
Exosomes Released by Melanoma Cells Prepare Sentinel Lymph Nodes for Tumor Metastasis
resolves10.1002/eji.1830190819
Molecules relevant for T cell‐target cell interaction are present in cytolytic granules of human T lymphocytes
resolves10.1182/blood.V94.11.3791
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
resolves10.1038/85438
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
resolves10.1016/j.colsurfb.2011.05.013
Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy
resolves10.4049/jimmunol.1003884
Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
resolves10.1016/j.bcmd.2005.03.005
Role of exosomes in sperm maturation during the transit along the male reproductive tract
resolves10.1016/j.jprot.2010.06.006
Exosomes: Extracellular organelles important in intercellular communication
resolves10.1158/1078-0432.CCR-05-0810
More Efficient Induction of HLA-A*0201-Restricted and Carcinoembryonic Antigen (CEA)–Specific CTL Response by Immunization with Exosomes Prepared from Heat-Stressed CEA-Positive Tumor Cells
resolves10.1158/0008-5472.CAN-06-3456
Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2
resolves10.1371/journal.pone.0003694
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
resolves10.1111/j.1349-7006.2010.01650.x
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
resolves10.1634/stemcells.2005-0342
Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
resolves10.1002/hep.21704
Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes
resolves10.1084/jem.20011700
Mesenchymal Stem Cells in Perichondrium Express Activated Leukocyte Cell Adhesion Molecule and Participate in Bone Marrow Formation
resolves10.1002/ar.1128
Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors
resolves10.1089/scd.2007.0036
Molecular and Proteomic Characterization of Human Mesenchymal Stem Cells Derived from Amniotic Fluid: Comparison to Bone Marrow Mesenchymal Stem Cells
resolves10.1634/stemcells.22-5-649
Human Placenta‐Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential
resolves10.1016/j.cellbi.2006.03.009
Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells
resolves10.1177/0022034509340867
Mesenchymal Stem Cells Derived from Dental Tissues
<i>vs</i>
. Those from Other Sources: Their Biology and Role in Regenerative Medicine
resolves10.1016/j.yjmcc.2009.12.021
Derivation and characterization of human fetal MSCs: An alternative cell source for large-scale production of cardioprotective microparticles
resolves10.1634/stemcells.2006-0420
Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs
resolves10.1038/sj.gt.3303067
Human mesenchymal stem cells: from basic biology to clinical applications
resolves10.1159/000080341
Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue
resolves10.1002/jcp.20959
From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells
resolves10.1016/j.jacc.2009.06.055
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
resolves10.1016/S0140-6736(08)60690-X
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
resolves10.1136/gut.2010.215152
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
resolves10.1002/stem.570
Concise Review: Bone Marrow for the Treatment of Spinal Cord Injury: Mechanisms and Clinical Applications
resolves10.1089/scd.2009.0164
Efficacy of Autologous Bone Marrow–Derived Stem Cell Transplantation in Patients With Type 2 Diabetes Mellitus
resolves10.1634/stemcells.2007-0637
Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views
resolves10.1016/j.bbrc.2007.01.045
Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment
resolves10.1161/CIRCULATIONAHA.104.527937
Allogeneic Mesenchymal Stem Cell Transplantation in Postinfarcted Rat Myocardium
resolves10.1016/j.ymthe.2006.05.016
Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation
resolves10.1038/mt.2010.192
Paracrine Factors of Multipotent Stromal Cells Ameliorate Lung Injury in an Elastase-induced Emphysema Model
resolves10.1073/pnas.132252399
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
resolves10.1161/hc0102.101442
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
resolves10.1096/fj.05-5211com
Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement
resolves10.1016/j.scr.2008.02.002
Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium
resolves10.1152/ajprenal.00007.2005
Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms
resolves10.1371/journal.pone.0001886
Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing
resolves10.1002/jcp.21592
The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair
resolves10.1016/j.jss.2006.11.006
Mesenchymal Stem Cells Attenuate Hypoxic Pulmonary Vasoconstriction by a Paracrine Mechanism
resolves10.1038/nm0405-367
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
resolves10.1016/j.scr.2011.01.001
Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction
resolves10.4049/jimmunol.171.7.3426
Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens
resolves10.1097/01.TP.0000045055.63901.A9
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation
resolves10.1016/S0301-472X(01)00769-X
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
resolves10.1182/blood.V99.10.3838
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
resolves10.1046/j.1365-3083.2003.01176.x
Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex
resolves10.1182/blood-2004-04-1559
Human mesenchymal stem cells modulate allogeneic immune cell responses
resolves10.1186/1479-5876-9-47
Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs
resolves10.2217/rme.11.35
Mesenchymal Stem Cell Exosome: a Novel Stem Cell-Based Therapy for Cardiovascular Disease
resolves10.1016/j.scr.2008.07.006
Generating mESC-derived insulin-producing cell lines through an intermediate lineage-restricted progenitor line
The 5 references without a DOI — listed, not checked
no DOI — not checkedPhase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors
no DOI — not checkedCardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells
no DOI — not checkedEpigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes
no DOI — not checkedExosome/microvesicle-mediated epigenetic reprogramming of cells
no DOI — not checkedMesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.addr.2012.07.001"><img src="https://citestamp.com/citestamped/10.1016/j.addr.2012.07.001/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.addr.2012.07.001)